This Small-Cap Vaccine Company Offers 14.5% Upisde, Vetr Crowd Says
August 24, 2016 at 14:48 PM EDT
Shares of small cap clinical-stage vaccine company Novavax, Inc. (NASDAQ: NVAX) have lost more than 14.5 percent since the beginning ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.